Atomistry » Bromine » PDB 4d4j-4g6v » 4d4j
Atomistry »
  Bromine »
    PDB 4d4j-4g6v »
      4d4j »

Bromine in PDB 4d4j: Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound

Enzymatic activity of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound

All present enzymatic activity of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound:
2.7.1.105; 3.1.3.46;

Protein crystallography data

The structure of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound, PDB code: 4d4j was solved by S.A.Stgallay, N.Bennett, S.Critchlow, G.Davies, J.E.Debreczeni, N.Evans, G.Holdgate, N.P.Jones, L.Leach, S.Maman, S.Mcloughlin, M.Preston, L.Rigoreau, A.Thomas, G.Walker, J.Walsch, R.A.Ward, E.Wheatley, J.Winter, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 88.71 / 3.00
Space group P 65 2 2
Cell size a, b, c (Å), α, β, γ (°) 102.430, 102.430, 258.630, 90.00, 90.00, 120.00
R / Rfree (%) 18.97 / 20.69

Bromine Binding Sites:

The binding sites of Bromine atom in the Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound (pdb code 4d4j). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound, PDB code: 4d4j:

Bromine binding site 1 out of 1 in 4d4j

Go back to Bromine Binding Sites List in 4d4j
Bromine binding site 1 out of 1 in the Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br1449

b:66.8
occ:0.75
BR A:BKI1449 0.0 66.8 0.8
C15 A:BKI1449 1.9 61.8 0.8
C14 A:BKI1449 2.8 59.1 0.8
C16 A:BKI1449 2.8 59.2 0.8
O A:LEU238 3.1 47.7 1.0
CG1 A:VAL214 3.8 43.8 1.0
CG1 A:ILE241 3.9 43.7 1.0
C A:LEU238 4.0 47.0 1.0
CD1 A:ILE241 4.0 47.4 1.0
C13 A:BKI1449 4.1 57.3 0.8
C17 A:BKI1449 4.1 56.6 0.8
CA A:LEU238 4.2 42.0 1.0
CE2 A:PHE221 4.3 43.1 1.0
CB A:LEU238 4.3 42.7 1.0
CA A:GLY218 4.3 47.1 1.0
CD2 A:LEU238 4.3 51.1 1.0
CZ A:PHE221 4.5 40.8 1.0
CG2 A:VAL214 4.6 43.5 1.0
C12 A:BKI1449 4.7 55.1 0.8
N A:GLY218 4.7 48.3 1.0
O A:ILE241 4.7 45.0 1.0
CB A:VAL214 4.8 44.5 1.0
CG A:LEU238 5.0 47.7 1.0

Reference:

S.A.Stgallay, N.Bennett, S.Critchlow, G.Davies, J.E.Debreczeni, N.Evans, G.Holdgate, N.P.Jones, L.Leach, S.Maman, S.Mcloughlin, M.Preston, L.Rigoreau, A.Thomas, G.Walker, J.Walsch, R.A.Ward, E.Wheatley, J.Winter. Identifying A Novel Series of PFKFB3 Inhibitors As A Metabolic Approach to Treating Cancer From Hts, Biophysical and Biochemical Methods To Be Published.
Page generated: Sat Dec 12 02:18:57 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy